GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
88.20
+2.55 (2.98%)
Nov 21, 2025, 9:54 AM EST - Market open
GRAIL Employees
GRAIL had 1,000 employees as of December 31, 2024. The number of employees decreased by 360 or -26.47% compared to the previous year.
Employees
1,000
Change (1Y)
-360
Growth (1Y)
-26.47%
Revenue / Employee
$141,827
Profits / Employee
-$406,241
Market Cap
3.44B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GRAL News
- 2 days ago - GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 7 days ago - Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold - Seeking Alpha
- 8 days ago - GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - GRAIL Reports Third Quarter 2025 Financial Results - PRNewsWire
- 16 days ago - GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference - PRNewsWire
- 16 days ago - Top Biotech Stocks Riding The Rally - Seeking Alpha
- 22 days ago - GRAIL to Announce Third Quarter 2025 Financial Results - PRNewsWire
- 25 days ago - GRAIL: Buy Τhe Test That Could Redefine Cancer Screening - Seeking Alpha